Oder einloggen mit
Twitter Twitter
Facebook Facebook
Apple Apple     
Oder einloggen mit
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Startseite
  2. Aktien
  3. Deutschland
  4. Xetra
  5. Bayer AG
  6. News
  7. Andere Sprachen
    BAYN   DE000BAY0017   BAY001


Verzögert Xetra  -  17:36 05.10.2022
48.65 EUR   +0.01%
05.10.Bayer schließt 2,6-Milliarden-Dollar-Verkauf der Environmental Science Professional Unit ab
28.09.DAX-Chefs verdienen 24 Prozent mehr - Vergütungstransparenz sinkt
26.09.Bayer erhält grünes Licht von der japanischen Zulassungsbehörde für Augenmedikamente für Frühgeborene
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über BAYER AG
05.10.Bayer : achève la vente d'une activité à Cinven
05.10.Bayer Completes $2.6 Billion Sale of Environmental Science Professional Unit
05.10.Bayer : completes sale of its Environmental Science Professional business to Cinven
04.10.Bayer boekt weer juridisch succes
03.10.Optus Confirms More Than Two Million Customers' Identity Documents Affected by Hack
03.10.Optus Hires Deloitte to Review Cyberattack
29.09.Bayer CropScience Gets Board Nod to Sell Environmental Science Business for Nearly $14 ..
27.09.Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Exten..
27.09.Santen Pharmaceutical Co., Ltd. - Ophthalmic VEGF inhibitor Eylea Solution for Intravit..
27.09.Australia's No. 2 telco Optus, government clash over massive data breach
26.09.U.S. farmers urge Washington to challenge Mexico's looming ban on GM corn
26.09.Bayer Gets Japanese Regulatory Nod For Eye Drug in Preterm Infants
26.09.Bayer : traitement par Elyea autorisé au Japon
24.09.Australia's Optus contacts customers caught in cyber attack
23.09.Australia's Optus says up to 10 million customers caught in cyber attack
22.09.Energia: Ahk Italien, supportare rinnovabili per favorire transizione green
22.09.Optus warns cyberattack may have exposed Australian client details
22.09.Singtel's Australian Unit Optus Hit by Cyberattack
20.09.Materials Shares Fall Ahead of Fed Rate Decision -- Materials Roundup
20.09.Food Supply Stays Tight as Disappointing U.S. Harvest Adds to Global Challenges -- Comm..
20.09.Syngenta Group Appoints Li Fanrong As Chairman
20.09.Biotech corn and soy widely used, consumers still wary of GM wheat
20.09.As war, drought hit global crops, Argentina gambles on GM wheat
20.09.Fitch Affirms Elanco's IDR at 'BB'; Outlooks Remains Negative
19.09.Environmental groups ask investors to vote against P&G CEO, directors
15.09.Bayer CEO says supply shortages cut crop protection sales in 2022
15.09.Transcript : Bayer Aktiengesellschaft - Special Call
14.09.La chimie allemande s'attend à une lourde chute de production en 2022
13.09.BASF SE : En el ojo de la tormenta
13.09.Bayer has started search for successor for CEO Baumann -Bloomberg
13.09.Germany's Bayer Starts Looking for New CEO
13.09.Bayer start zoektocht naar nieuwe CEO - media
13.09.Bayer Begins Search for CEO Werner Baumann's Successor, Bloomberg Reports
13.09.Opiniones de los analistas del día: Shell, CRH, Bayer..
12.09.DEERE : des logiciels, des tracteurs autonomes et des pulvérisateurs de cultures i..
12.09.BASF SE : Dans l'œil du cyclone
12.09.MarketScreener's World Press Review : September 12, ..
12.09.Amazon réinitialise, UPS embauche, Deere mise sur l..
12.09.Lonza nomme un nouveau directeur pour la division Cellule et Gène
10.09.Novartis: succès relatif d'un programme contre le cancer du foie
09.09.Health Care Up as Biotech Niche Continues to Gain -- Health Care Roundup
09.09.Bayer AG - Aflibercept 8 mg first to achieve extended injection intervals of 16 weeks i..
08.09.Regeneron Says Aflibercept 8 mg for Diabetic Macular Edema and wAMD Met Primary Endpoin..
08.09.Bayer-Regeneron Eye Drug Shows Effect at Higher Doses in Late-Stage Studies
08.09.Regeneron Shares Soar on Positive Trial News
08.09.Regeneron Says Retinal Treatment Trials Met Primary Endpoints
05.09.Bayer - Kerendia receives updated label in the U.S. to include findings from Phase III ..
05.09.Wyld Networks Starts Deployment Of Contact Sensor Developed With Bayer For Beehive Data
05.09.L'Europe colmate les fuites
05.09.Bolsa de Madrid: Europa tapa las fugas
05.09.EN DIRECT DES MARCHES : Sanofi, ArcelorMittal, Alstom, Volkswagen,..
05.09.Germany's Bayer Enters $40 Million Settlement Deal Over Whistleblower Claims in US
02.09.Bayer settles kickback and fraud allegations for $40 million
02.09.Bayer pagará 40 millones de dólares para resolver reclamaciones sobre tres medicamentos..
02.09.Bayer Agrees to $40 Million DOJ Settlement Over Alleged Kickbacks, False Claims
02.09.U.S. says Bayer to pay $40 million to resolve whistleblower lawsuits
02.09.U.s. says bayer to pay $40 million to resolve claims over allege…
02.09.Bayer : la notice de la finérénone mise à jour aux USA
02.09.Bayer Wins US FDA Nod To Add Kidney, Cardiovascular Outcomes In Label For Kerendia
02.09.Bayer : Kerendia™ (finerenone) receives updated label in the U.S. to include finding..
01.09.Bayer : Kimberly Mathisen appointed to the Supervisory Board of Bayer AG
01.09.Bayer : Kimberly Mathisen remplace Fei-Fei Li au conseil
31.08.Opiniones de los analistas del día: ASML, Asos, BP, S..
31.08.Tentative de reconnexion
31.08.Avis d'analystes du jour : ASML, Asos, Kone, Sixt, KBC, Bayer, ..
30.08.Bayer Demonstrates Commitment to Advancing Oncology by Showcasing New Data from Innovat..
30.08.Bayer : nouvelles données positives de Kerendia
30.08.Bayer : UBS réitère son conseil sur le titre
30.08.Syngenta boosts Q2 results ahead of planned IPO
29.08.Bayer's Kerendia Lowers Death Risk in Chronic Kidney Disease, Diabetes Patients
29.08.Bayer : début d'un essai de phase III sur un anticoagulant
29.08.Bayer : New data indicate positive effects of Kerendia™ (finerenone) on mortality in..
29.08.Opiniones de los analistas del día: Bayer, Apple, Str..
29.08.Bolsa de Madrid: Powell arrasa con la subida de agosto
29.08.Bayer Commences Late-stage Study of Potential Stroke Prevention Drug
28.08.Bayer Initiates Phase III Study Program for Investigational Oral FXIa Inhibitor Asundex..
28.08.Bayer initiates asundexian Phase III study program
28.08.Bayer : initiates landmark Phase III study program to investigate oral FXIa inhibitor asun..
24.08.BrainVectis, a subsidiary of AskBio, receives clearance to conduct Phase I/II clinical ..
23.08.Bayer Unit Receives Clearance For French Trial Of Huntington's Disease Therapy
23.08.Bayer : autorisation d'essai dans la maladie de Huntington
22.08.L'agenda di domani
22.08.Bayer : s'apprête à présenter de nouvelles données cliniques
22.08.Bayer : to present data from cardiovascular portfolio, including a late-breaking presentat..
22.08.L'agenda della settimana
22.08.Analyse-Sanofi sous pression pour relancer son portefeuille de médicaments
19.08.L'agenda della prossima settimana
19.08.Bayer Showcases Leadership in Breakthrough Innovations and Sustainable, Tailored Soluti..
19.08.Mirena from Bayer approved in the US for extended duration of use in contraception
18.08.Bayer's Intrauterine Contraceptive Wins OK in US for Extended Use Duration
18.08.Bayer's Mirena Gets FDA Approval for Extended Use as Contraceptive
18.08.Bayer : la FDA approuve une utilisation prolongée de Mirena
18.08.Bayer : Mirena® from Bayer approved in the US for extended duration of use in contraceptio..
18.08.Bayer : effectue un don pour soutenir le déminage en Ukraine
17.08.Perrigo Refutes Involvement in Recent Notice of Dismissal of Claims, Impending Trial Ov..
17.08.GSK Says No Payment Made After Zantac Plaintiff Drops Lawsuit
17.08.GSK : un patient américain se retire dans l'affaire Zantac
17.08.GSK: un plaignant dans un procès du Zantac aux USA va retirer sa plainte
17.08.GSK Says Plaintiff In First Zantac Case Set For US Trial Drops Lawsuit
Anstehende Termine für BAYER AG